Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Short term Debt (2021)

Historic Short term Debt for Whitehawk Therapeutics (WHWK) over the last 1 years, with Q4 2021 value amounting to $258000.0.

  • Whitehawk Therapeutics' Short term Debt changed N/A to $258000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $258000.0, marking a year-over-year change of. This contributed to the annual value of $258000.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Short term Debt of $258000.0 as of Q4 2021.
  • Whitehawk Therapeutics' Short term Debt's 5-year high stood at $258000.0 during Q4 2021, with a 5-year trough of $22000.0 in Q3 2021.